Blog | HemaCare

Efficient Way to Generate iPSCs for the Treatment of Multiple Sclerosis

Oct 13, 2014 1:00:01 PM / by Shweta posted in Brain Inflammation, disease-state cells, Independent validation, induced pluripotent stem cells, Innovation, iPSCs, regenerative medicine, research, stem cell therapy, stem cells, tissue engineering

0 Comments

Scientists have developed an accelerated protocol to generate functional oligodendrocytes for the treatment of multiple sclerosis

In one of our previous blogs we have described that Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by brain inflammation, which arises when the nervous system is attacked by the body’s own immune cells. MS can develop because of viral infection, genetic defects or environmental factors. As yet, the exact etiology of the disease is unfortunately unknown.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts